J1456 – Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1456
- Long description
- Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- Short description
- Inj, fosaprepitant (teva)
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2023
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J1456?
J1456 is a HCPCS Level II code for injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg.
Does Medicare cover J1456?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1448 – Injection, trilaciclib, 1mg
- J1449 – Injection, eflapegrastim-xnst, 0.1 mg
- J1450 – Injection fluconazole, 200 mg
- J1451 – Injection, fomepizole, 15 mg
- J1452 – Injection, fomivirsen sodium, intraocular, 1.65 mg
- J1453 – Injection, fosaprepitant, 1 mg
- J1454 – Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455 – Injection, foscarnet sodium, per 1000 mg
- J1457 – Injection, gallium nitrate, 1 mg
- J1458 – Injection, galsulfase, 1 mg
- J1459 – Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1460 – Injection, gamma globulin, intramuscular, 1 cc
- J1551 – Injection, immune globulin (cutaquig), 100 mg
- J1552 – Injection, immune globulin (alyglo), 500 mg
- J1553 – Injection, immune globulin (yimmugo), 100 mg
- J1554 – Injection, immune globulin (asceniv), 500 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.